Header cover image
  • Investing Ideas
  • /
  • Norwegian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Norwegian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals

Results

1

0 new

High return on equity, past performance and sound balance sheet.

1 companies

Vistin Pharma

Market Cap: NOK 1.1b

Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.

VISTN

NOK 24.30

7D

-6.5%

1Y

7.5%